Innovative Mediquip Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Innovative Mediquip
Innovative Mediquip Private Limited (IMPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 July 2011 and has a history of 13 years and six months. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhishek Saxena and Shweta Saxena serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U52100UP2011PTC045795
- Company No.
045795
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Innovative Mediquip?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Saxena  | Director | 20-Jul-2011 | Current |
| Shweta Saxena | Director | 20-Jul-2011 | Current |
Financial Performance of Innovative Mediquip.
Innovative Mediquip Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Innovative Mediquip?
In 2017, Innovative Mediquip had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
P N B Finance And Industries LimitedShweta Saxena is a mutual person
Pearl Print Well LimitedShweta Saxena is a mutual person
- Kanchanmani Investments And Finance Private Limited
Shweta Saxena is a mutual person
- Artee Viniyoga Limited
Shweta Saxena is a mutual person
- The Speaking Tree Foundation
Shweta Saxena is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Innovative Mediquip?
Unlock and access historical data on people associated with Innovative Mediquip, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovative Mediquip, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovative Mediquip's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.